Rahul Dhanuka

“This indeed is a product-specific growth from the domain of insecticides. So, we all understand and appreciate it was an El Nino year. Internally, we kind of regrouped to understand that what kind of challenges farmers will face with an El Nino year and what will be the opportunities.”

“So, we have acquired Iprovelicarb and its variants and Tritaminol and its variants from Bayer for global markets. And as we speak, we have already established some customers in various markets and already business started with them.”

“Yeah, so this is absolutely a wonderful point that we are expanding to international markets and we have also explored inorganic growth by these two brand additions as well as we are doing backward integration on both these products.”